
Rapid Medical Diagnostic Kits Market (Application: Clinical Testing [Infectious Disease Testing, Cholesterol Monitoring, Substance Abuse Testing, Fertility & Pregnancy Testing, and Blood Glucose Testing], Home Use [Infectious Disease Testing, Cholesterol
Description
Rapid Medical Diagnostic Kits Market (Application: Clinical Testing [Infectious Disease Testing, Cholesterol Monitoring, Substance Abuse Testing, Fertility & Pregnancy Testing, and Blood Glucose Testing], Home Use [Infectious Disease Testing, Cholesterol Monitoring, Substance Abuse Testing, Fertility & Pregnancy Testing, and Blood Glucose Testing], and Veterinary; and Technology: Lateral Flow, Flow-through, Solid-phase, and Agglutination Assays) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
Rapid Medical Diagnostic Kits Market – Scope of Report
TMR’s report on the rapid medical diagnostic kits market studies the past as well as current growth trends and opportunities to gain valuable insights into the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global rapid medical diagnostic kits market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global rapid medical diagnostic kits market during the forecast period.
The report has been prepared after extensive primary and secondary research. Primary research involved a bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion-makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global rapid medical diagnostic kits.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study the various phenomenon in the global rapid medical diagnostic kits.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global rapid medical diagnostic kits. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global rapid medical diagnostic kits.
The market overview section of the report demonstrates the qualitative analysis of the market dynamics of the global rapid medical diagnostic kits market and includes information about the drivers, restraints, opportunities, Porter’s Five Forces analysis, and market attractiveness analysis of the market.
The report delves into the competitive landscape of the global rapid medical diagnostic kits. Key players operating in the global rapid medical diagnostic kits market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the rapid medical diagnostic kits market that have been profiled in this report.
The company profiles section of the report includes information about the major market players. Leading players in the market include Abbott Laboratories, Abaxis, Inc., Alere, Inc., Becton, Dickinson & Company, BioRad Laboratories, F. Hoffmann La Roche, MegaCor, Trinity Biotech, and Zoetis, Inc.
Key Questions Answered in Rapid Medical Diagnostic Kits Market Report
What is the scope of growth of product companies in the global rapid medical diagnostic kits?
What will be the Y-o-Y growth of the global rapid medical diagnostic kits market between 2017 and 2028?
What is the influence of changing trends in technologies on the global rapid medical diagnostic kits?
Will North America be the most profitable market for rapid medical diagnostic kits providers?
Which factors are anticipated to hamper the growth of the global rapid medical diagnostic kits market during the forecast period?
Which are the leading companies in the global rapid medical diagnostic kits?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global rapid medical diagnostic kits market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the rapid medical diagnostic kits market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global rapid medical diagnostic kits market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the rapid medical diagnostic kits market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the rapid medical diagnostic kits market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the rapid medical diagnostic kits market more reliably and accurately.
Rapid Medical Diagnostic Kits Market – Scope of Report
TMR’s report on the rapid medical diagnostic kits market studies the past as well as current growth trends and opportunities to gain valuable insights into the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global rapid medical diagnostic kits market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global rapid medical diagnostic kits market during the forecast period.
The report has been prepared after extensive primary and secondary research. Primary research involved a bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion-makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global rapid medical diagnostic kits.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study the various phenomenon in the global rapid medical diagnostic kits.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global rapid medical diagnostic kits. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global rapid medical diagnostic kits.
The market overview section of the report demonstrates the qualitative analysis of the market dynamics of the global rapid medical diagnostic kits market and includes information about the drivers, restraints, opportunities, Porter’s Five Forces analysis, and market attractiveness analysis of the market.
The report delves into the competitive landscape of the global rapid medical diagnostic kits. Key players operating in the global rapid medical diagnostic kits market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the rapid medical diagnostic kits market that have been profiled in this report.
The company profiles section of the report includes information about the major market players. Leading players in the market include Abbott Laboratories, Abaxis, Inc., Alere, Inc., Becton, Dickinson & Company, BioRad Laboratories, F. Hoffmann La Roche, MegaCor, Trinity Biotech, and Zoetis, Inc.
Key Questions Answered in Rapid Medical Diagnostic Kits Market Report
What is the scope of growth of product companies in the global rapid medical diagnostic kits?
What will be the Y-o-Y growth of the global rapid medical diagnostic kits market between 2017 and 2028?
What is the influence of changing trends in technologies on the global rapid medical diagnostic kits?
Will North America be the most profitable market for rapid medical diagnostic kits providers?
Which factors are anticipated to hamper the growth of the global rapid medical diagnostic kits market during the forecast period?
Which are the leading companies in the global rapid medical diagnostic kits?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global rapid medical diagnostic kits market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the rapid medical diagnostic kits market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global rapid medical diagnostic kits market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the rapid medical diagnostic kits market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the rapid medical diagnostic kits market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the rapid medical diagnostic kits market more reliably and accurately.
Table of Contents
104 Pages
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Rapid Medical Diagnostic Kits Market
- 4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, 2017–2028
- 4.4.1. Market Revenue Projections (US$ Mn)
- 5. Key Insights
- 5.1. Technological Advancements
- 5.2. Pipeline Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic's Impact on Industry (value chain and short / mid / long term impact)
- 6. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, By Application
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Application, 2017–2028
- 6.3.1. Clinical Testing
- 6.3.1.1. Infectious Disease Testing
- 6.3.1.2. Cholesterol Monitoring
- 6.3.1.3. Substance Abuse Testing
- 6.3.1.4. Fertility & Pregnancy Testing
- 6.3.1.5. Blood Glucose Testing
- 6.3.2. Home Use
- 6.3.2.1. Infectious Disease Testing
- 6.3.2.2. Cholesterol Monitoring
- 6.3.2.3. Substance Abuse Testing
- 6.3.2.4. Fertility & Pregnancy Testing
- 6.3.2.5. Blood Glucose Testing
- 6.3.3. Veterinary
- 6.4. Market Attractiveness By Application
- 7. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, By Technology
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Technology, 2017–2028
- 7.3.1. Lateral Flow
- 7.3.2. Flow-through
- 7.3.3. Solid-phase
- 7.3.4. Agglutination Assays
- 7.4. Market Attractiveness Analysis, By Technology
- 8. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, By Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness Analysis, By Region
- 9. North America Rapid Medical Diagnostic Kits Market Analysis and Forecast
- 9.1. Introduction
- 9.1.1. Key Findings
- 9.2. Market Value Forecast, by Application, 2017–2028
- 9.2.1. Clinical Testing
- 9.2.1.1. Infectious Disease Testing
- 9.2.1.2. Cholesterol Monitoring
- 9.2.1.3. Substance Abuse Testing
- 9.2.1.4. Fertility & Pregnancy Testing
- 9.2.1.5. Blood Glucose Testing
- 9.2.2. Home Use
- 9.2.2.1. Infectious Disease Testing
- 9.2.2.2. Cholesterol Monitoring
- 9.2.2.3. Substance Abuse Testing
- 9.2.2.4. Fertility & Pregnancy Testing
- 9.2.2.5. Blood Glucose Testing
- 9.2.3. Veterinary
- 9.3. Market Value Forecast, by Technology, 2017–2028
- 9.3.1. Lateral Flow
- 9.3.2. Flow-through
- 9.3.3. Solid-phase
- 9.3.4. Agglutination Assays
- 9.4. Market Value Forecast, by Country, 2017–2028
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Application
- 9.5.2. By Technology
- 9.5.3. By Country
- 10. Europe Rapid Medical Diagnostic Kits Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Application, 2017–2028
- 10.2.1. Clinical Testing
- 10.2.1.1. Infectious Disease Testing
- 10.2.1.2. Cholesterol Monitoring
- 10.2.1.3. Substance Abuse Testing
- 10.2.1.4. Fertility & Pregnancy Testing
- 10.2.1.5. Blood Glucose Testing
- 10.2.2. Home Use
- 10.2.2.1. Infectious Disease Testing
- 10.2.2.2. Cholesterol Monitoring
- 10.2.2.3. Substance Abuse Testing
- 10.2.2.4. Fertility & Pregnancy Testing
- 10.2.2.5. Blood Glucose Testing
- 10.2.3. Veterinary
- 10.3. Market Value Forecast, by Technology, 2017–2028
- 10.3.1. Lateral Flow
- 10.3.2. Flow-through
- 10.3.3. Solid-phase
- 10.3.4. Agglutination Assays
- 10.4. Market Value Forecast, by Country/Sub-Region, 2017–2028
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Spain
- 10.4.5. Italy
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Application
- 10.5.2. By Technology
- 10.5.3. By Country/Sub-Region
- 11. Asia Pacific Rapid Medical Diagnostic Kits Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Application, 2017–2028
- 11.2.1. Clinical Testing
- 11.2.1.1. Infectious Disease Testing
- 11.2.1.2. Cholesterol Monitoring
- 11.2.1.3. Substance Abuse Testing
- 11.2.1.4. Fertility & Pregnancy Testing
- 11.2.1.5. Blood Glucose Testing
- 11.2.2. Home Use
- 11.2.2.1. Infectious Disease Testing
- 11.2.2.2. Cholesterol Monitoring
- 11.2.2.3. Substance Abuse Testing
- 11.2.2.4. Fertility & Pregnancy Testing
- 11.2.2.5. Blood Glucose Testing
- 11.2.3. Veterinary
- 11.3. Market Value Forecast, by Technology, 2017–2028
- 11.3.1. Lateral Flow
- 11.3.2. Flow-through
- 11.3.3. Solid-phase
- 11.3.4. Agglutination Assays
- 11.4. Market Value Forecast, by Country/Sub-Region, 2017–2028
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Application
- 11.5.2. By Technology
- 11.5.3. By Country/Sub-Region
- 12. Latin America Rapid Medical Diagnostic Kits Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Application, 2017–2028
- 12.2.1. Clinical Testing
- 12.2.1.1. Infectious Disease Testing
- 12.2.1.2. Cholesterol Monitoring
- 12.2.1.3. Substance Abuse Testing
- 12.2.1.4. Fertility & Pregnancy Testing
- 12.2.1.5. Blood Glucose Testing
- 12.2.2. Home Use
- 12.2.2.1. Infectious Disease Testing
- 12.2.2.2. Cholesterol Monitoring
- 12.2.2.3. Substance Abuse Testing
- 12.2.2.4. Fertility & Pregnancy Testing
- 12.2.2.5. Blood Glucose Testing
- 12.2.3. Veterinary
- 12.3. Market Value Forecast, by Technology, 2017–2028
- 12.3.1. Lateral Flow
- 12.3.2. Flow-through
- 12.3.3. Solid-phase
- 12.3.4. Agglutination Assays
- 12.4. Market Value Forecast, by Country/Sub-Region, 2017–2028
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Application
- 12.5.2. By Technology
- 12.5.3. By Country/Sub-Region
- 13. Middle East & Africa Rapid Medical Diagnostic Kits Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Application, 2017–2028
- 13.2.1. Clinical Testing
- 13.2.1.1. Infectious Disease Testing
- 13.2.1.2. Cholesterol Monitoring
- 13.2.1.3. Substance Abuse Testing
- 13.2.1.4. Fertility & Pregnancy Testing
- 13.2.1.5. Blood Glucose Testing
- 13.2.2. Home Use
- 13.2.2.1. Infectious Disease Testing
- 13.2.2.2. Cholesterol Monitoring
- 13.2.2.3. Substance Abuse Testing
- 13.2.2.4. Fertility & Pregnancy Testing
- 13.2.2.5. Blood Glucose Testing
- 13.2.3. Veterinary
- 13.3. Market Value Forecast, by Technology, 2017–2028
- 13.3.1. Lateral Flow
- 13.3.2. Flow-through
- 13.3.3. Solid-phase
- 13.3.4. Agglutination Assays
- 13.4. Market Value Forecast, by Country/Sub-Region, 2017–2028
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Application
- 13.5.2. By Technology
- 13.5.3. By Country/Sub-Region
- 14. Competition Landscape
- 14.1. Market Player - Competition Matrix (by tier and size of companies)
- 14.2. Company Profiles
- 14.2.1. Abbott Laboratories
- 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.1.2. Product Portfolio
- 14.2.1.3. Financial Overview
- 14.2.1.4. Strategic Overview
- 14.2.1.5. SWOT Analysis
- 14.2.2. Abaxis, Inc.
- 14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.2.2. Product Portfolio
- 14.2.2.3. Financial Overview
- 14.2.2.4. Strategic Overview
- 14.2.2.5. SWOT Analysis
- 14.2.3. Alere, Inc.
- 14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.3.2. Product Portfolio
- 14.2.3.3. Financial Overview
- 14.2.3.4. Strategic Overview
- 14.2.3.5. SWOT Analysis
- 14.2.4. Becton Dickinson & Company
- 14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.4.2. Product Portfolio
- 14.2.4.3. Financial Overview
- 14.2.4.4. Strategic Overview
- 14.2.4.5. SWOT Analysis
- 14.2.5. BioRad Laboratories
- 14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.5.2. Product Portfolio
- 14.2.5.3. Financial Overview
- 14.2.5.4. Strategic Overview
- 14.2.5.5. SWOT Analysis
- 14.2.6. F. Hoffmann La Roche
- 14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.6.2. Product Portfolio
- 14.2.6.3. Financial Overview
- 14.2.6.4. Strategic Overview
- 14.2.6.5. SWOT Analysis
- 14.2.7. MegaCor
- 14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.7.2. Product Portfolio
- 14.2.7.3. Financial Overview
- 14.2.7.4. Strategic Overview
- 14.2.7.5. SWOT Analysis
- 14.2.8. Trinity Biotech
- 14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.8.2. Product Portfolio
- 14.2.8.3. Financial Overview
- 14.2.8.4. Strategic Overview
- 14.2.8.5. SWOT Analysis
- 14.2.9. Zoetis, Inc.
- 14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.9.2. Product Portfolio
- 14.2.9.3. Financial Overview
- 14.2.9.4. Strategic Overview
- 14.2.9.5. SWOT Analysis
- 14.2.10. Other prominent players
- 14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.2.10.2. Product Portfolio
- 14.2.10.3. Financial Overview
- 14.2.10.4. Strategic Overview
- 14.2.10.5. SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.